ODwyer, 2001, J Intern Med, 250, 3, 10.1046/j.1365-2796.2001.00823.x
Mauro, 2001, Oncologist, 6, 233, 10.1634/theoncologist.6-3-233
Lemonick, 2001, Time, 157, 62
Brown, 2001, Fortune, 143, 166
Amos, 2002, Hum Mutat, 19, 324, 10.1002/humu.10061
Bottles, 2001, Physician Exec, 27, 58
Evans, 2003, N Engl J Med, 348, 538, 10.1056/NEJMra020526
Weinshilboum, 2003, N Engl J Med, 348, 529, 10.1056/NEJMra020021
Osborne, 1998, Breast Cancer Res Treat, 51, 227, 10.1023/A:1006132427948
Wilbur, 1992, Mod Pathol, 5, 79
Ciocca, 2000, Endocrine, 13, 1, 10.1385/ENDO:13:1:1
Jordan, 2003, Nat Rev Drug Discov, 2, 205, 10.1038/nrd1031
Locker, 1998, Cancer Treat Rev, 24, 221, 10.1016/S0305-7372(98)90051-2
Miller, 2002, Cancer Invest, 20, 15, 10.1081/CNV-120014882
Buzdar, 2002, Cancer, 95, 2006, 10.1002/cncr.10908
Jordan, 2003, J Med Chem, 46, 883, 10.1021/jm020449y
Jordan, 2003, J Med Chem, 46, 1081, 10.1021/jm020450x
Rubnitz, 1999, Curr Opin Hematol, 6, 229, 10.1097/00062752-199907000-00006
Gleissner, 2001, Expert Rev Mol Diagn, 1, 191, 10.1586/14737159.1.2.191
Grimwade, 2002, Leukemia, 16, 1959, 10.1038/sj.leu.2402721
Reichert, 2001, Nat Biotechnol, 19, 819, 10.1038/nbt0901-819
Kiyoi, 2002, Leuk Lymphoma, 43, 1541, 10.1080/1042819021000002866
Ross, 1998, Oncologist, 3, 237, 10.1634/theoncologist.3-4-237
Slamon, 2001, N Engl J Med, 344, 783, 10.1056/NEJM200103153441101
Schnitt, 2001, Am J Clin Pathol, 116, 806, 10.1309/WMN8-VTR5-DUGF-X12L
Hayes, 2002, Semin Oncol, 29, 231, 10.1053/sonc.2002.32899
Masood, 2002, Microsc Res Tech, 59, 102, 10.1002/jemt.10181
Wang, 2001, Am J Clin Pathol, 116, 495, 10.1309/TMUW-G4WB-LXJ2-FUDN
Wang, 2000, J Clin Pathol, 53, 374, 10.1136/jcp.53.5.374
Tanner, 2000, Am J Pathol, 157, 1467, 10.1016/S0002-9440(10)64785-2
Zhao, 2002, Mod Pathol, 15, 657, 10.1038/modpathol.3880582
Hortobagyi, 2001, Semin Oncol, 28, 43, 10.1016/S0093-7754(01)90108-3
McKeage, 2002, Drugs, 62, 209, 10.2165/00003495-200262010-00008
Shawver, 2002, Cancer Cell, 1, 117, 10.1016/S1535-6108(02)00039-9
Ligibel, 2002, Semin Oncol, 29, 38, 10.1053/sonc.2002.34054
Mass, 2001, J Clin Oncol, 195, 85
Vogel, 2002, J Clin Oncol, 20, 719, 10.1200/JCO.2002.20.3.719
Seidman, 2001, J Clin Oncol, 19, 2587, 10.1200/JCO.2001.19.10.2587
Fornier, 2003, Oncology, 16, 1340
Mendelsohn, 2000, Oncogene, 19, 6550, 10.1038/sj.onc.1204082
McCarthy, 2003, Lancet, 361, 1959, 10.1016/S0140-6736(03)13603-3
Elliott, 2001, Am J Clin Pathol, 116, 637, 10.1309/44HW-5YCJ-FLLP-3R56
Adams, 2002, Oncologist, 7, 9, 10.1634/theoncologist.7-1-9
Orlowski, 2002, J Clin Oncol, 20, 4420, 10.1200/JCO.2002.01.133
Schenkein, 2002, Clin Lymphoma, 3, 49, 10.3816/CLM.2002.n.011
Weinstein, 2000, N Engl J Med, 343, 1408, 10.1056/NEJM200011093431910
Slonim, 2001, Pharmacogenomics, 2, 123, 10.1517/14622416.2.2.123
Taylor, 2001, Trends Mol Med, 7, 507, 10.1016/S1471-4914(01)02183-9
Weber, 2001, Anticancer Res, 21, 3631
Ingelman-Sundberg, 2001, Mutat Res, 482, 11, 10.1016/S0027-5107(01)00205-6
Davis, 2002, Curr Opin Hematol, 9, 333, 10.1097/00062752-200207000-00011
van de Vijver, 2002, N Engl J Med, 347, 1999, 10.1056/NEJMoa021967
Zanders, 2000, Pharmacogenomics, 1, 375, 10.1517/14622416.1.4.375
Los, 2002, Cytometry, 47, 66, 10.1002/cyto.10037
Slonim, 2001, Pharmacogenomics, 2, 123, 10.1517/14622416.2.2.123
Ramaswamy, 2002, J Clin Oncol, 20, 1932, 10.1200/JCO.2002.20.7.1932
Schena, 1995, Science, 270, 467, 10.1126/science.270.5235.467
Ayers, 2002, Breast Cancer Res Treat, 76, S64
Hanahan, 2000, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9
